Edition:
United States

People: Transition Therapeutics Inc (TTH.TO)

TTH.TO on Toronto Stock Exchange

2.07CAD
29 Jul 2016
Change (% chg)

$0.00 (+0.00%)
Prev Close
$2.07
Open
$2.07
Day's High
$2.07
Day's Low
$2.07
Volume
115
Avg. Vol
25,783
52-wk High
$3.87
52-wk Low
$0.89

Pastrak, Aleksandra 

Dr. Aleksandra Pastrak is Vice President - Clinical Development and Medical Officer of Transition Therapeutics Inc. Dr. Pastrak has been with Transition since 1999 and served as VP, Research since 2005 until she was appointed VP, Clinical Development in 2011. With her expertise in medicine and pharmacology, she has made an invaluable contribution to the development of our clinical programs for various therapeutic products. Dr. Pastrak holds an MD from the School of Medicine at the University of Belgrade and M.Sc. and Ph.D. degrees in Clinical Pharmacology from the University of Toronto.

Basic Compensation

Total Annual Compensation, CAD 300,937
Restricted Stock Awards, CAD --
Long-Term Incentive Plans, CAD --
All Other, CAD 106,774
Fiscal Year Total, CAD 407,711

Options Compensation

  Quantity Market Value
Exercisable 62,553 294,692.00
Unexercisable 174,113 158,864.00
Exercised 742 6,010.00
Name Fiscal Year Total

Tony Cruz

424,876

Carl Damiani

199,228

Nicole Rusaw

316,054

Bruce Connop

287,182

Aleksandra Pastrak

407,711

Louis Alexopoulos

--
As Of  29 Jun 2013